LncRNA CRNDE, highly expressed in few cells in MGH26 and MGH28, was previously found to promote glioma cell growth and invasion through mTOR signaling and might serve as a potential novel therapeutic target for glioma [21]. This evidence concerns the gene MTOR and central nervous system cancer.